Related Experiment Video
Updated: Feb 25, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
Published on: September 11, 2020
Streptococcus pneumoniae serotype 19A: worldwide epidemiology.
Raul Isturiz1, Heather L Sings1, Betsy Hilton1
1a Pfizer Inc , Collegeville , PA , USA.
The 13-valent pneumococcal conjugate vaccine (PCV13) offers superior protection against Streptococcus pneumoniae serotype 19A compared to PCV7 and PCV10. PCV13 reduces disease and nasopharyngeal carriage, providing herd protection for all age groups.
Area of Science:
- * Pneumococcal disease epidemiology and vaccine impact.
- * Immunology and vaccine efficacy.
- * Public health and infectious disease surveillance.
Background:
- * Streptococcus pneumoniae causes significant global morbidity and mortality.
- * Serotype 19A emerged as a leading cause of pneumococcal disease after PCV7 introduction.
- * Latest generation pneumococcal conjugate vaccines (PCV10, PCV13) aim to address remaining disease burden.
Purpose of the Study:
- * To review the impact of PCV10 and PCV13 on serotype 19A.
- * To compare immune responses elicited by PCV7, PCV10, and PCV13 against serotype 19A.
- * To assess the effect of these vaccines on nasopharyngeal carriage and disease incidence.
Main Methods:
- * Analysis of data from surveillance systems, randomized controlled trials, and observational studies.
- * Evaluation of immune responses to PCV7, PCV10, and PCV13.
- * Assessment of nasopharyngeal carriage rates and invasive pneumococcal disease (IPD) incidence.
Main Results:
- * PCV13 elicits significantly higher functional immune responses against serotype 19A than PCV7 and PCV10.
- * PCV13 demonstrated a direct impact on vaccinated populations and reduced 19A nasopharyngeal carriage in children.
- * PCV7 and PCV10 showed limited cross-protection and minimal impact on 19A carriage, leading to continued transmission.
Conclusions:
- * PCV13 is more effective than PCV7 and PCV10 in controlling serotype 19A pneumococcal disease.
- * PCV13-induced herd protection reduces IPD in unvaccinated individuals, including children and adults.
- * Continued surveillance is essential to monitor the long-term impact of PCV13 on pneumococcal disease dynamics.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...

